These complexes recruited co-repressor RIP140 instead of co-activator steroid receptor coactivator-1 (SRC1), leading to a reduction in SREBP-1and downstream lipogenic enzyme level during early fasting or positive glycemic periods prior to hypoglycemia and PKA activation (Takeuchi et al., 2016). The gene discussed is NCOA1; the disease is Hypoglycemia.